Caplin Point listed on Forbes Asia’s “200 Best under a Billion” for 2024
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
The facility will manufacture tablets, capsules, and injections for the oncology segment
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Subscribe To Our Newsletter & Stay Updated